Stay updated on Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a maintenance update to the study record page. This reflects a system-level update rather than any changes to the study information presented.
    Difference
    0.0%
    Check dated 2026-06-29T08:31:14.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Recruitment is now listed as 'No longer looking for participants', indicating that enrollment is closed. The page also adds new sections for How to Read a Study Record, Common Questions, and How to Join a Study, and updates the Intervention/Treatment header formatting along with a revision note.
    Difference
    0.4%
    Check dated 2026-06-15T08:11:14.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing v3.5.4. This reflects a page revision update and does not change the study details or results.
    Difference
    0.0%
    Check dated 2026-06-08T04:30:26.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.5.4 replaces the previous v3.5.3, indicating an updated page build without changes to displayed content.
    Difference
    0.0%
    Check dated 2026-05-17T10:14:25.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study record dates have been updated to include new entries (2026-05-01, 2027-02-25, 2026-04-17, 2026-04) and remove earlier entries (2025-05-07, 2026-03-25, 2025-04-29, 2025-04), reflecting adjustments to the posting and QC timeline on the page.
    Difference
    0.2%
    Check dated 2026-05-03T01:20:23.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page version/build indicator was updated from v3.5.2 to v3.5.3, reflecting a minor administrative release rather than a substantive change to the trial’s study details.
    Difference
    0.0%
    Check dated 2026-04-25T18:39:53.000Z thumbnail image

Stay in the know with updates to Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.